We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Rapid, Ultra-Sensitive, PCR-Free Detection Method Makes Genetic Analysis More Accessible

By LabMedica International staff writers
Posted on 22 Apr 2025

Genetic testing has been an important method for detecting infectious diseases, diagnosing early-stage cancer, ensuring food safety, and analyzing environmental DNA. More...

For a long time, polymerase chain reaction (PCR) has been the gold standard for analyzing DNA changes. With the onset of the COVID-19 pandemic, the term "PCR" became widely recognized. However, PCR tests are expensive, time-consuming, and require specialized lab equipment and trained personnel. While PCR-based genetic testing gained significant attention during the pandemic, light-based methods are now offering a PCR-free alternative for genetic analysis.

Researchers at Osaka Metropolitan University (Osaka, Japan) have developed a groundbreaking light-induced DNA detection method that employs heterogeneous probe particles. This innovative technique enables highly sensitive and rapid genetic analysis without the need for PCR amplification. This advance promises to make genetic testing faster, more affordable, and more precise, benefiting fields like medicine, environmental science, and portable diagnostics. Unlike PCR, which amplifies DNA sequences by creating millions of copies for detection, this new approach directly identifies DNA by concentrating it and enhancing its specificity through optical forces and the photothermal effect. In their study, published in ACS Sensors, the researchers used heterogeneous probe particles, including gold nanoparticles and polystyrene microparticles, to create a detection system. These probes are short DNA sequences that are designed to bind with complementary sequences in the target DNA.

This process, known as DNA hybridization, results in the formation of detectable DNA pairs through fluorescence. The solution containing the target DNA and probe particles was then irradiated with laser light. When the particle size aligns with the laser wavelength, a phenomenon called Mie scattering occurs, which generates optical forces that move the particles and speed up DNA hybridization. The gold nanoparticles absorb the laser light, producing localized heat, also known as the photothermal effect, which further enhances the specificity of the hybridization. By eliminating the need for PCR amplification, this method reduces both the cost and complexity of genetic testing while delivering faster results. This innovation has the potential to make genetic analysis more accessible, with wide-ranging applications in healthcare and personal health tracking.

“Our light-induced method detects DNA without the need for PCR,” wrote the study’s lead authors. “Using just about five minutes of laser light irradiation, our method demonstrated great potential for accurate mutation detection with a sensitivity one order of magnitude higher than that of digital PCR. We aim to apply this PCR-free technology to high-sensitivity cancer diagnostics, quantum life science research, and even at-home or environmental DNA testing.”

Related Links:
Osaka Metropolitan University


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Dr. Maria “Ken” Figueroa is investigating how epigenetics can inform treatment paths for cancer patients. (Image Credit: Sylvester Comprehensive Cancer Center)

DNA Methylation May Help Predict Treatment Response in Myelodysplastic Syndromes

Myelodysplastic syndromes (MDS) are disorders in which the bone marrow does not produce healthy blood cells normally. Treatment selection can be challenging because clinicians cannot reliably predict which... Read more

Hematology

view channel
Image: These new ANC reference ranges can help clinicians more accurately interpret neutrophil counts, reduce unnecessary testing and treatment interruptions, and help support more equitable care. (Photo courtesy of the American Society of Hematology)

New Reference Ranges Clarify Normal Neutrophil Counts in Duffy-Null Patients

Duffy-null status is a common genetic trait associated with naturally lower circulating white blood cell counts. It affects about 10% of the U.S. population and more than 66% of people with African or... Read more

Immunology

view channel
Image: Melioidosis is a serious, sometimes fatal infection caused by Burkholderia pseudomallei, a bacterium found in tropical and subtropical soil and surface water. (Image Credit: Adobe Stock)

Antibody Testing Informs Melioidosis Diagnosis and Surveillance in Emerging Regions

Melioidosis is a serious and sometimes fatal infection caused by the soil- and water-dwelling bacterium Burkholderia pseudomallei. People and animals can contract the disease through exposure to contaminated... Read more

Industry

view channel
Image: Siemens Healthineers has begun carving out its in vitro diagnostics business as a standalone company named Olyrian Diagnostics (Photo courtesy of Siemens Healthineers)

Siemens Healthineers Begins Transition Toward Standalone Olyrian Diagnostics Business

Siemens Healthineers has begun carving out its in vitro diagnostics business, which will operate as Olyrian Diagnostics. The new name will be introduced in stages as the business prepares to become a standalone... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.